Hugel announced on the 1st that the PDO suture brand 'Licellvi (Korean product name: Blue Rose Forte)' was launched in Thailand.
Licellvi is a suture brand containing PDO (polydioxanone) produced by J-World, a subsidiary of Hugel and a domestic medical suture manufacturer. By adopting a differentiated non-heat treatment processing method, the shortcomings of existing PDO sutures, which are weak to heat, have been complemented.
...
In particular, Hugel continues its overwhelming leadership position in Thailand with its botulinum toxin product 'Letybo' (Korean product name: Botulax), achieving approximately 50% market share, and will actively utilize synergy effects such as improving Licellvi brand awareness. plan.
A Hugel official said, “We plan to quickly target the local market by adding the systematic marketing capabilities of Hugel, a global medical aesthetics company, to J-World’s outstanding product capabilities.” He added, “In the local market, our botulinum toxin product ‘Letybo’ has ranked first in market share. “As this continues, we are expecting a synergy effect between the two products,” he said.
Copyright © Public News. Reproduction and redistribution prohibited.
( https://www.psnews.co.kr/news/articleView.html?idxno=2026005 )
Hugel announced on the 1st that the PDO suture brand 'Licellvi (Korean product name: Blue Rose Forte)' was launched in Thailand.
Licellvi is a suture brand containing PDO (polydioxanone) produced by J-World, a subsidiary of Hugel and a domestic medical suture manufacturer. By adopting a differentiated non-heat treatment processing method, the shortcomings of existing PDO sutures, which are weak to heat, have been complemented.
...
In particular, Hugel continues its overwhelming leadership position in Thailand with its botulinum toxin product 'Letybo' (Korean product name: Botulax), achieving approximately 50% market share, and will actively utilize synergy effects such as improving Licellvi brand awareness. plan.
A Hugel official said, “We plan to quickly target the local market by adding the systematic marketing capabilities of Hugel, a global medical aesthetics company, to J-World’s outstanding product capabilities.” He added, “In the local market, our botulinum toxin product ‘Letybo’ has ranked first in market share. “As this continues, we are expecting a synergy effect between the two products,” he said.
Copyright © Public News. Reproduction and redistribution prohibited.
( https://www.psnews.co.kr/news/articleView.html?idxno=2026005 )